A Comparative Investment Analysis of Batch Versus Continuous Pharmaceutical Manufacturing Technologies. [PDF]
J Pharm Innov, 2022 Purpose This study examines the risks and economics associated with investing in continuous (CM) versus conventional batch manufacturing for production of oral solid dosage pharmaceutical (OSD) products in the USA and abroad.
Rossi CV.
europepmc +2 more sources
Defossilization of pharmaceutical manufacturing
Current Opinion in Green and Sustainable Chemistry, 2022 Lea Wollensack +2 more
openaire +2 more sources
Independent research and development, technology accumulation and innovation performance: Evidence from China's pharmaceutical manufacturing industry. [PDF]
PLoS One, 2022 Technology accumulation plays a vital role in research and development (R&D) activities. This paper used technology accumulation as the threshold variable to construct a dynamic panel threshold model to explore the technology accumulation threshold ...
Wang S, Liu Q, Chen Y.
europepmc +2 more sources
AAPS Journal, 2022 Industry 4.0 has started to transform the manufacturing industries by embracing digitalization, automation, and big data, aiming for interconnected systems, autonomous decisions, and smart factories. Machine learning techniques, such as artificial neural
Brigitta Nagy +3 more
semanticscholar +1 more source
Applying Lean Six Sigma Methodology to a Pharmaceutical Manufacturing Facility: A Case Study
Processes, 2021 This research examines a case study on the implementation of an effective approach to advanced Lean Six Sigma problem-solving within a pharmaceutical manufacturing site which manufactures acetaminophen (paracetamol containing pain relief) tablets. Though
Brian Byrne, Olivia McDermott, J. Noonan
semanticscholar +1 more source
The sustainability of emerging technologies for use in pharmaceutical manufacturing
Expert Opinion on Drug Delivery, 2022 Introduction Sustainability within the pharmaceutical industry is becoming a focal point for many companies, to improve the longevity and social perception of the industry.
E. Weaver, Collette O'Hagan, D. Lamprou
semanticscholar +1 more source
Systematic approach to cross-contamination risk management in the production of medicinal products
Разработка и регистрация лекарственных средств, 2022 Introduction. Good Manufacturing Practice (GMP) requires drug manufacturers to apply risk management principles in their operations. One of the main risks to the quality and safety of pharmaceuticals is cross-contamination.
A. A. Dzerzhinskaya +2 more
doaj +1 more source
Pharmaceutical Manufacturer Assistance Programs [PDF]
Archives of Internal Medicine, 2002 While there have been many public discussions concerning Medicare covering outpatient prescription medications, currently, Medicare does not pay for most outpatient prescriptions. Meanwhile, costs associated with prescription medications as well as the number of underinsured patients are rapidly increasing.
Marie A, Chisholm, Joseph T, DiPiro
openaire +2 more sources
RESEARCH ON OUTPUT VALUE AND SOCIAL RESPONSIBILITY OF CHINESE PHARMACEUTICAL INDUSTRY BASED ON MULTIVARIATE STATISTICS [PDF]
Malaysian E Commerce Journal, 2017 The pharmaceutical industry is a sunrise industry in China’s high-tech industries. This article studies the situation of Chinese pharmaceutical manufacturing industryfrom two aspects,which are output value and responsibility.The greater the output ...
Li Yajie, Peng Ruqin
doaj +1 more source
Emerging Challenges and Opportunities in Pharmaceutical Manufacturing and Distribution
Processes, 2021 The rise of personalised and highly complex drug product profiles necessitates significant advancements in pharmaceutical manufacturing and distribution.
Miriam Sarkis +3 more
semanticscholar +1 more source